Yanagawa Fumiki, Sugiura Shinji, Kanamori Toshiyuki
Drug Assay Device Research Group, Biotechnology Research Institute for Drug Discovery, National Institute of Advanced Industrial Science and Technology (AIST), Central 5th, 1-1-1 Higashi, Tsukuba, Ibaraki 305-8565, Japan.
Regen Ther. 2016 Mar 17;3:45-57. doi: 10.1016/j.reth.2016.02.007. eCollection 2016 Mar.
The development of biologically relevant three-dimensional (3D) tissue constructs is essential for the alternative methods of organ transplantation in regenerative medicine, as well as the development of improved drug discovery assays. Recent technological advances in hydrogel microfabrication, such as micromolding, 3D bioprinting, photolithography, and stereolithography, have led to the production of 3D tissue constructs that exhibit biological functions with precise 3D microstructures. Furthermore, microfluidics technology has enabled the development of the perfusion culture of 3D tissue constructs with vascular networks. In this review, we present these hydrogel microfabrication technologies for the reconstruction and cultivation of 3D tissues. Additionally, we discuss current challenges and future perspectives of 3D tissue engineering.
生物相关三维(3D)组织构建体的发展对于再生医学中器官移植的替代方法以及改进药物发现检测方法的发展至关重要。水凝胶微制造技术的最新进展,如微成型、3D生物打印、光刻和立体光刻,已导致生产出具有精确3D微观结构并展现生物功能的3D组织构建体。此外,微流控技术已推动了具有血管网络的3D组织构建体的灌注培养的发展。在本综述中,我们介绍了用于3D组织重建和培养的这些水凝胶微制造技术。此外,我们还讨论了3D组织工程当前面临的挑战和未来前景。